Evidence map›Paper›PMID 37047264›Full record

ArticleInternational journal of molecular sciences2023

Airway and Lung Organoids from Human-Induced Pluripotent Stem Cells Can Be Used to Assess CFTR Conductance.

Anna Demchenko, Ekaterina Kondrateva, Vyacheslav Tabakov, Anna Efremova, Diana Salikhova, Tatiana Bukharova, Dmitry Goldshtein, Maxim Balyasin, Natalia Bulatenko, Elena Amelina and 2 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Advancements in theFrontiers in toxicology · 2025
    Review
  12. Article
  13. Review
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Anna DemchenkoLaboratory of Genome Editing, Research Centre for Medical Genetics, Moskvorechye, 1, 115522 Moscow, Russia.ORCID 0000-0002-4460-7627
Ekaterina KondratevaLaboratory of Genome Editing, Research Centre for Medical Genetics, Moskvorechye, 1, 115522 Moscow, Russia.
Vyacheslav TabakovMoscow Branch of the Biobank "All-Russian Collection of Biological Samples of Hereditary Diseases", Research Centre for Medical Genetics, Moskvorechye, 1, 115522 Moscow, Russia.
Anna EfremovaStem Cell Genetics Laboratory, Research Centre for Medical Genetics, Moskvorechye, 1, 115522 Moscow, Russia.
Diana SalikhovaStem Cell Genetics Laboratory, Research Centre for Medical Genetics, Moskvorechye, 1, 115522 Moscow, Russia.ORCID 0000-0001-7842-7635
Tatiana BukharovaStem Cell Genetics Laboratory, Research Centre for Medical Genetics, Moskvorechye, 1, 115522 Moscow, Russia.ORCID 0000-0003-0481-256X
Dmitry GoldshteinStem Cell Genetics Laboratory, Research Centre for Medical Genetics, Moskvorechye, 1, 115522 Moscow, Russia.
Maxim BalyasinScientific and Educational Resource Center, Peoples' Friendship University of Russia, Miklukho-Maklaya, 6, 117198 Moscow, Russia.
Natalia BulatenkoStem Cell Genetics Laboratory, Research Centre for Medical Genetics, Moskvorechye, 1, 115522 Moscow, Russia.
Elena AmelinaLaboratory of Cystic Fibrosis, Research Institute of Pulmonology, 11th Parkovaya Str., 32/4, 105077 Moscow, Russia.
Alexander LavrovLaboratory of Genome Editing, Research Centre for Medical Genetics, Moskvorechye, 1, 115522 Moscow, Russia.ORCID 0000-0003-4962-6947
Svetlana SmirnikhinaLaboratory of Genome Editing, Research Centre for Medical Genetics, Moskvorechye, 1, 115522 Moscow, Russia.
Research Centre for Medical Genetics · RUPeoples' Friendship University of Russia · RURussian Research Institute of Hematology and Transfusiology · RU

Funding

The research was funded by the state assignment of Ministry of Science and Higher Education of the Russian Federation for RCMG None
6 · The paper itself

Abstract

Airway and lung organoids derived from human-induced pluripotent stem cells (hiPSCs) are current models for personalized drug screening, cell-cell interaction studies, and lung disease research. We analyzed the existing differentiation protocols and identified the optimal conditions for obtaining organoids. In this article, we describe a step-by-step protocol for differentiating hiPSCs into airway and lung organoids. We obtained airway and lung organoids from a healthy donor and from five donors with cystic fibrosis. Analysis of the cellular composition of airway and lung organoids showed that airway organoids contain proximal lung epithelial cells, while lung organoids contain both proximal and distal lung epithelial cells. Forskolin-induced swelling of organoids derived from a healthy donor showed that lung organoids, as well as airway organoids, contain functional epithelial cells and swell after 24 h exposure to forskolin, which makes it a suitable model for analyzing the cystic fibrosis transmembrane conductance regulator (CFTR) channel conductance in vitro. Thus, our results demonstrate the feasibility of generating and characterizing airway and lung organoids from hiPSCs, which can be used for a variety of future applications.

Indexed as

Cystic Fibrosis Transmembrane Conductance RegulatorInduced Pluripotent Stem CellsColforsinEpithelial CellsHumansLungOrganoidsCFTR protein, humanColforsinCystic Fibrosis Transmembrane Conductance RegulatorCFTRcystic fibrosisdifferentiationhuman-induced pluripotent stem cellsorganoids

Identifiers

PMID37047264
PMCPMC10094586
OpenAlexW4361221048

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.